EPAS1 and pheochromocytoma: Mutations of the EPAS1 gene, which codes for the HIF-2α, have been described in 6% of patients with pheochromocytoma and paraganglioma and strongly suggest a pathogenic and, therapeutically speaking, targetable role for hypoxia (43, 44).